DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. Funding Opportunities
  3. Synopsis of Open Program Funding Opportunities

Funding Opportunities

Synopsis of Open Program Funding Opportunities

FY23 Amyotrophic Lateral Sclerosis Research Program (ALSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline  
Pilot Clinical Trial Award (PCTA) Program Announcement
Application Instructions 		February 8, 2023
  • The maximum allowable funding for the entire period of performance is $2,000,000 for direct costs.
  • Clinical Care Tier: The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
April 13, 2023
5:00 p.m. Eastern Time

Application:
July 13, 2023
11:59 p.m. Eastern Time
Clinical Biomarker Development Award (CBDA) Program Announcement
Application Instructions 		February 8, 2023
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 2 years.
 Pre-Application (Preproposal):
April 13, 2023
5:00 p.m. Eastern Time

Application:
July 13, 2023
11:59 p.m. Eastern Time
Therapeutic Development Award (TDA) Program Announcement
Application Instructions 		February 8, 2023
  • The maximum allowable funding for the entire period of performance is $1,500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
April 13, 2023
5:00 p.m. Eastern Time

Application:
July 13, 2023
11:59 p.m. Eastern Time
Therapeutic Idea Award (TIA) Program Announcement
Application Instructions 		February 8, 2023
  • The maximum allowable funding for the entire period of performance is $600,000 for direct costs.
  • Biomarker Option: The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 2 years.
 Pre-Application (Preproposal):
April 13, 2023
5:00 p.m. Eastern Time

Application:
July 13, 2023
11:59 p.m. Eastern Time

FY23 Autism Research Program (ARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Career Development Award (CDA) Program Announcement
Application Instructions 		March 3, 2023
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $550,000 in direct costs (plus indirect costs).
 Pre-Application (Preproposal):
April 19, 2023 5:00 p.m. Eastern Time (ET)

Application:
July 20, 2023 11:59 p.m. ET
Clinical Trial Award (CTA) Program Announcement
Application Instructions 		March 3, 2023
  • The maximum period of performance is 4 years.

Single PI:

  • The maximum allowable funding for the entire period of performance is $1,900,000 in direct costs (plus indirect costs).

Early-Career Investigator Partnering PI Option:

  • The maximum allowable funding for the entire period of performance is $2,200,000 in direct costs (plus indirect costs).
 Pre-Application (Preproposal):
April 19, 2023 5:00 p.m. Eastern Time (ET)

Application:
July 20, 2023 11:59 p.m. ET
Idea Development Award (IDA) Program Announcement
Application Instructions 		March 3, 2023
  • The maximum period of performance is 3 years.

Single PI or Partnering PI Option:

  • The maximum allowable funding for the entire period of performance is $550,000 in direct costs (plus indirect costs).
 Pre-Application (Preproposal):
April 19, 2023 5:00 p.m. Eastern Time (ET)

Application:
July 20, 2023 11:59 p.m. ET

FY23 Breast Cancer Research Program (BCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Research Extension Award (CREA) Program Announcement
Application Instructions		 February 28, 2023 Clinical Research Extension Award:
  • The maximum allowable funding for the entire period of performance is $5M for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
Clinical Research Extension Award with Partnering PI Option:
  • The maximum allowable funding for the entire period of performance is $6M for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application
(Letter of Intent):
June 6, 2023
5:00 p.m. Eastern Time

Application:
June 22, 2023
11:59 p.m. Eastern Time
ERP

FY23 Epilepsy Research Program (ERP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award (IDA) Program Announcement
Application Instructions 		February 3, 2023 Level I:
  • The maximum allowable funding for the entire period of performance is $450,000 for direct costs.
  • The maximum period of performance is 3 years.
Level II:
  • The maximum allowable funding for the entire period of performance is $650,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application
(Letter of Intent):
 May 19, 2023
5:00 p.m. Eastern Time

Application:
 June 23, 2023
11:59 p.m. Eastern Time
Research Partnership Award (RPA) Program Announcement
Application Instructions 		February 3, 2023
  • The maximum allowable funding for the entire period of performance is $1,200,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application
(Letter of Intent):
 May 19, 2023
5:00 p.m. Eastern Time

Application:
 June 23, 2023
11:59 p.m. Eastern Time
Virtual Post-Traumatic Epilepsy Research Center Faculty Award
(Virtual-P-TERC-F)		 Program Announcement
Application Instructions 		February 3, 2023
  • The maximum allowable funding for the entire period of performance is $525,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application
(Letter of Intent):
 May 19, 2023
5:00 p.m. Eastern Time

Application:
 June 23, 2023
11:59 p.m. Eastern Time
Leveraging Research Award (LRA) Program Announcement
Application Instructions 		February 3, 2023
  • The maximum allowable funding for the entire period of performance is $250,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application
(Letter of Intent):
 May 19, 2023
5:00 p.m. Eastern Time

Application:
 June 23, 2023
11:59 p.m. Eastern Time
LCRP

FY23 Lung Cancer Research Program (LCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Career Development Award
(CDA)		 Program Announcement
Application Instructions 		February 16, 2023
  • Maximum funding of $375,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 3 years.
 Pre-Application
(Letter of Intent):
May 2, 2023
5:00 p.m. Eastern time (ET)

Letter of Intent is required.

Application:
May 23, 2023
11:59 p.m. ET
Concept Award
(CA)		 Program Announcement
Application Instructions 		February 16, 2023
  • Maximum funding of $100,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 1 year.
 Pre-Application
(Letter of Intent):
May 2, 2023
5:00 p.m. ET

Letter of Intent is required.

Application:
May 23, 2023
11:59 p.m. ET
Idea Development Award
(IDA)		 Program Announcement
Application Instructions 		February 16, 2023
  • Maximum funding of $525,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 3 years.
 Pre-Application
(Preproposal):
May 10, 2023
5:00 p.m. ET

Preproposal is required; application submission is by invitation only.

Application:
August 3, 2023
11:59 p.m. ET
Translational Research Award
(TRA)		 Program Announcement
Application Instructions 		February 16, 2023 Level 1
  • Maximum funding of $900,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 3 years.
Level 2 – Clinical Trial Option
  • Maximum funding of $1,200,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 4 years.
 Pre-Application
(Preproposal):
May 10, 2023
5:00 p.m. ET

Preproposal is required; application submission is by invitation only.

Application:
August 3, 2023
11:59 p.m. ET

FY23 Ovarian Cancer Research Program (OCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Ovarian Cancer – Clinical Trial Academy Leadership Award (OCCTALA) Program Announcement
Application Instructions
March 23, 2023
  • The maximum allowable funding for the entire period of performance is $1,750,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.

 Pre-Application
(Letter of Intent):
May 26, 2023
5:00 p.m. Eastern Time

Application:
July 21, 2023
11:59 p.m. Eastern Time
Clinical Trial Award (CTA) Program Announcement
Application Instructions
March 7, 2023
  • The maximum allowable funding for the entire period of performance is $2,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.

 Pre-Application
(Letter of Intent):
May 26, 2023
5:00 p.m. Eastern Time

Application:
July 21, 2023
11:59 p.m. Eastern Time
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions
March 7, 2023
  • The maximum allowable funding for the entire period of performance is $2,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.

 Pre-Application
(Letter of Intent):
May 26, 2023
5:00 p.m. Eastern Time

Application:
July 21, 2023
11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		February 16, 2023
  • The maximum allowable funding for the entire period of performance is:
    • $600,000 for direct costs for a single PI.
    • $800,000 for direct costs for Partnering PIs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application
(Preproposal):
April 17, 2023
5:00 p.m. Eastern Time

Application:
July 21, 2023
11:59 p.m. Eastern Time
Ovarian Cancer Academy Award - Early-Career Investigator (OCA) Program Announcement
Application Instructions 		February 16, 2023
  • The maximum allowable funding for the entire period of performance is $725,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application
(Preproposal):
April 17, 2023
5:00 p.m. Eastern Time

Application:
July 21, 2023
11:59 p.m. Eastern Time
Pilot Award (PA) Program Announcement
Application Instructions 		February 16, 2023
  • The maximum allowable funding for the entire period of performance is $300,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 2 years.
 Pre-Application
(Preproposal):
April 17, 2023
5:00 p.m. Eastern Time

Application:
July 21, 2023
11:59 p.m. Eastern Time

FY23 Peer Reviewed Alzheimer's Research Program (PRARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Transforming Care Award (TCA) Program Announcement
Application Instructions 		March 27, 2023
  • The maximum allowable funding for the entire period of performance is:
    • $1.0 million (M) in total costs for the base option
    • $1.2M in total costs for the CITPO
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application
(Letter of Intent):
 May 31, 2023
5:00 p.m. Eastern Time

Application:
 July 10, 2023
11:59 p.m. Eastern Time
Transforming Diagnosis Award (TDA) Program Announcement
Application Instructions 		March 27, 2023
  • The maximum allowable funding for the entire period of performance is $2.5M for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application
(Letter of Intent):
 May 31, 2023
5:00 p.m. Eastern Time

Application:
 July 10, 2023
11:59 p.m. Eastern Time
Transforming Research Award (TRA) Program Announcement
Application Instructions 		March 27, 2023
  • The maximum allowable funding for the entire period of performance is $1.0M for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application
(Letter of Intent):
 May 31, 2023
5:00 p.m. Eastern Time

Application:
 July 10, 2023
11:59 p.m. Eastern Time

FY23 Peer Reviewed Medical Research Program (PRMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award (CTA) Program Announcement
Application Instructions 		February 1, 2023 Clinical Trial Option:
  • A funding limit is not defined; requested funding must be appropriate for the scope of work proposed.
  • The maximum period of performance for the clinical trial is 4 years.

Planning Phase with Clinical Trial Option:
  • The maximum allowable funding for the Planning Phase period of performance is $500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance for the planning phase is 18 months.
  • The maximum period of performance for the clinical trial is 4 years.
 Pre-Application
(Preproposal):
April 12, 2023
5:00 p.m. Eastern Time

Application:
July 19, 2023
11:59 p.m. Eastern Time
Focused Program Award (FPA) Program Announcement
Application Instructions 		February 1, 2023
  • The maximum allowable funding for the entire period of performance is $7.2 million for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.

 Pre-Application
(Preproposal):
April 12, 2023
5:00 p.m. Eastern Time

Application:
July 19, 2023
11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		February 1, 2023
  • The maximum allowable funding for the entire period of performance is $1.6 million for direct costs for single investigators and $2.0 million for partnering investigators.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.

 Pre-Application
(Letter of Intent):
April 19, 2023
5:00 p.m. Eastern Time

Application:
May 31, 2023
11:59 p.m. Eastern Time
Lifestyle and Behavioral Health Interventions Research Award (LBIRA) Program Announcement
Application Instructions 		February 1, 2023
  • The maximum allowable funding for the entire period of performance is $3.0 million for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.

 Pre-Application
(Letter of Intent):
April 19, 2023
5:00 p.m. Eastern Time

Application:
May 31, 2023
11:59 p.m. Eastern Time
Technology/Therapeutic Development Award (TTDA) Program Announcement
Application Instructions 		February 1, 2023 Funding Level 1:
  • The maximum allowable funding for the entire period of performance is $2.0 million for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance for the clinical trial is 4 years.

Funding Level 2:
  • The maximum allowable funding for the entire period of performance is $4.0 million for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance for the clinical trial is 4 years.

 Pre-Application
(Letter of Intent):
April 19, 2023
5:00 p.m. Eastern Time

Application:
May 31, 2023
11:59 p.m. Eastern Time

FY23 Spinal Cord Injury Research Program (SCIRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award (CTA) Program Announcement
Application Instructions 		March 30, 2023
  • The maximum allowable funding for the entire period of performance is $3.0 million (M) for direct costs.
  • Early-Career Partnering PI Option: Maximum allowable funding for the entire period of performance is $3.1M for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application
(Preproposal):
May 24, 2023
5:00 p.m. Eastern Time

Application:
September 7, 2023
11:59 p.m. Eastern Time
Clinical Translation Research Award (CTRA) Program Announcement
Application Instructions 		March 30, 2023
  • The maximum allowable funding for the entire period of performance is $1.25M for direct costs.
  • Early-Career Partnering PI Option: Maximum allowable funding for the entire period of performance is $1.35M for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application
(Preproposal):
May 24, 2023
5:00 p.m. Eastern Time

Application:
September 7, 2023
11:59 p.m. Eastern Time
Translational Research Award (TRA) Program Announcement
Application Instructions 		March 30, 2023
  • The maximum allowable funding for the entire period of performance is $1.25M for direct costs.
  • Early-Career Partnering PI Option: Maximum allowable funding for the entire period of performance is $1.35M for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application
(Preproposal):
May 24, 2023
5:00 p.m. Eastern Time

Application:
September 7, 2023
11:59 p.m. Eastern Time
Investigator-Initiated Research Award (IIRA) Program Announcement
Application Instructions 		March 30, 2023
  • The maximum allowable funding for the entire period of performance is $0.5M for direct costs.
  • Early-Career Partnering PI Option: Maximum allowable funding for the entire period of performance is $0.6M for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application
(Preproposal):
May 24, 2023
5:00 p.m. Eastern Time

Application:
September 7, 2023
11:59 p.m. Eastern Time

FY23 Tuberous Sclerosis Complex Research Program (TSCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Exploration – Hypothesis Development Award (EHDA) Program Announcement
Application Instructions 		March 15, 2023
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $150,000 in direct costs.
  • Indirect costs may be proposed in accordance With the institution's negotiated rate agreement.
 Pre-Application
(Letter of Intent):
June 8, 2023
5:00 p.m. Eastern Time (ET)

Application:
July 7, 2023 11:59 p.m. ET
Idea Development Award (IDA) Program Announcement
Application Instructions 		March 15, 2023
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $500,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
 Pre-Application
(Letter of Intent):
June 8, 2023
5:00 p.m. Eastern Time (ET)

Application:
July 7, 2023 11:59 p.m. ET
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions 		March 15, 2023
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $1,000,000 in direct costs.
  • The maximum allowable funding for the entire period of performance is $1,150,000 in direct costs for applications including a Partnering PI Option.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
 Pre-Application
(Letter of Intent):
June 8, 2023
5:00 p.m. Eastern Time (ET)

Application:
July 7, 2023 11:59 p.m. ET

CDMRP

Privacy Notice · External Links/Product Disclaimers · Research Programs · Funding Opportunities · Consumer Involvement · Search Awards · About Us

CDMRP © 2023

location icon

1077 Patchel Street Fort Detrick, MD 21702-5024

telephone icon

(301) 619-7071

About Us The CDMRP originated in 1992 via a Congressional appropriation to foster novel approaches to biomedical research in response to the expressed needs of its stakeholders-the American public, the military, and Congress.

- MRDC Family -

CDMRP | TATRC | USAARL | USAISR | USAMMDA | USAMRAA | USAMRICD | USAMRIID | USARIEM | WRAIR